Gene Query: DDAH1

Dataset Description Geneva Score
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 71.34
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 71.34
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 70.34
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 59.58
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 56.01
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 54.43
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 53.75
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 51.37
BET bromodomain inhibition 51.37
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 51.11
Lung Cancer Cell-Mediated Skeletal Muscle Mitochondrial Dysfunction is Mitigated by 1a,25-Dihydroxyvitamin D3 50.34
Analysis by Whole Transcriptome Sequencing of the Effects of LLC1 conditioned medium, LLC1 conditioned plus Calcitriol, non-conditioned medium, and non-conditioned medium plus Calcitriol on mRNA Expression in Primary Human Skeletal Muscle Cells 50.34
Statins modulate endothelial transcriptional profile by inhibiting EZH2 48.9
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 48.46
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 48.06
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 48.06
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 46.54
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 45.54
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 45.54
Conservative alteration of chromosomal expression pattern across human solid tumor types 45.25
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 44.96
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 44.33
Entrectinib Resistance in a Neuroblastoma Xenograft Model 44.24
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 43.81
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 42.38
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 42.38
PGE2 mediated gene expression changes in human cervical stromal cells 42.21
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 41.34
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 40.84
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 40.82
Gene expression profile of human iPSC-derived nephron progenitor cells 40.54
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 39.54
Redifferentiation of expanded human islet β cells by inhibition of ARX 39.0
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 38.97
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 38.12
Differentiation enhances Zika virus infection in neuronal brain cells 36.71
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 35.46
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 35.46
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 34.83
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 34.72
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 34.7
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 34.7
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 34.26
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients 33.41
Early response of human ovarian and fallopian tube surface epithelial cells to norepinephrine 32.92
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 31.75
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 31.75
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 31.2
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 31.18
Transcriptomic analyssis following EHMT1/2 inhibition 30.79
Differential gene expression in Jagged1 treated human dental pulp cells. 30.57
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 30.45
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 30.45
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 29.36
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 29.29
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 29.29
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 29.14
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 28.85
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 28.56
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 28.49
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 28.22
Transcriptome analysis upon C6orf203 silencing 28.19
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 27.72
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 27.41
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 27.09
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 26.91
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 26.73
Overexpression and knockdown experiment for circCSNK1G3 26.59
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 26.23
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 26.01
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 25.38
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 24.91
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 24.59
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 24.57
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 24.54
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 24.54
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 24.54
Knockdown of ADNP in HCT116 colon cancer cells 24.47
G-quadruplex structures mark human regulatory chromatin 24.46
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 24.21
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 24.17
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 23.81
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 23.77
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 23.57
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 23.28
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 23.18
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 23.18
Fbxo32 mediated gene expression program underlies EMT and metastasis 23.1
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 23.04
RNA-seq of human aneuploid cell lines with Trisomy 21 22.95
SUV420H2 knockdown in PANC-1 22.89
RNA Seq analysis of NKX2-5 Null and Het human embryonic stem cells in cardiomyogenesis 22.54
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 22.47
Differential analysis of gene regulation at transcript resolution by RNA-Seq 22.43
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 22.43
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 22.23
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 22.02
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 21.93
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 21.84
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 21.67
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 21.61
RNA sequencing of BT142 and TS603 cell lines 21.51
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 21.51
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 21.44
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 21.41
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 21.39
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 21.35
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 21.3
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 21.13
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 21.07
A prostate cancer chromatin interaction map 20.82
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 20.82
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 20.82
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 20.71
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 20.71
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 20.49
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 20.47
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 20.46
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 20.23
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 20.2
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 20.05
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 19.9
MYCi975 regulates MYC target genes 19.79
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 19.7
Transcriptome profiling of 5 human adenocarcinoma cell lines 19.65
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 19.52
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 19.4
Patient-derived luminal breast cancer xenografts with progestins 19.4
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 19.3
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 18.82
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 18.82
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 18.81
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 18.81
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 18.76
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 18.67
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 18.51
Identification of the role of polydom in neurofibromas 18.45
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 18.32
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 18.32
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 18.32
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 18.32
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 18.29
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 18.29
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 18.25
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 18.22
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 18.22
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 18.11
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 18.11
Genome wide miR-191 target profile determined by RIP and gene expression profiling 18.0
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 18.0
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 17.99
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 17.97
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 17.95
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 17.92
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 17.75
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 17.73
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 17.62
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 17.62
MicroRNA targetome analysis during HCMV infection 17.55
MYCL and EP400 are required for Max and MCPyV mediated gene activation 17.4
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 17.3
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 17.01
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 17.01
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 16.99
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 16.99
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 16.97
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 16.86
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 16.85
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 16.7
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 16.56
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 16.49
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 16.49
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 16.47
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 16.47
Transcriptome profiling of Normal and Cancerous Prostate Cells 16.44
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 16.43
Genome-wide chromatin analysis of Ewing sarcoma 16.38
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 16.38
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 16.35
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 16.35
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 16.35
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 16.34
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 16.34
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 16.27
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 16.26
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 16.24
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 16.21
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 16.18
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 16.17
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 16.04
Uridylation by TUT4 and TUT7 marks mRNA for degradation 15.9
Depicting early human development and germ cell origin with porcine embryos 15.89
RNA-Seq from early time points in the kidney differentiation protocol 15.84
CHCHD2 gene KO effect in iPSC drived motor neurons 15.8
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 15.49
The cohesin release factor WAPL restricts chromatin loop extension. 15.49
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 15.46
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 15.44
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 15.42
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 15.42
PNET animal model: new insights (II) 15.4
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 15.38
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 15.34
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 15.31
Identification of Nrf2 regulated genes by RNA sequencing 15.25
Nrf2 regulated genes in A549 cells 15.25
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 15.13
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 15.12
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 15.03
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 15.03
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 14.9
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 14.88
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 14.81
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 14.61
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 14.56
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 14.47
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 14.47
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 14.45
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 14.35
STRIPAK directs PP2A activity to promote oncogenic transformation 14.32
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 14.24
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 14.14
Chromatin-informed inference of transcriptional programs in gynecologic cancers 14.13
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 14.13
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 14.1
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 14.1
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 14.05
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 14.0
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 13.99
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 13.91
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 13.9
Generation of KRAS signatures using immortalized isogenic lung cells. 13.89
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 13.83
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 13.83
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 13.82
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 13.78
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 13.77
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 13.75
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 13.69
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 13.59
Toxoplasma gondii infection of human retinal pigment epithelial cells 13.59
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 13.57
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 13.57
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 13.46
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 13.44
Global analysis of alternative splicing regulated by RBM10 13.41
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  13.29
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 13.21
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 13.13
Identification of long noncoding RNAs regulated by p53 13.09
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 13.07
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 13.07
Characterization of parental and rociletinib-resistant derived H1975 cell lines 13.0
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 13.0
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 12.99
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 12.95
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 12.88
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 12.87
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 12.79
Non-coding regions are the main source of tumor-specific antigens 12.75
Non-coding regions are the main source of tumor-specific antigens [human] 12.75
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 12.72
Modeling Familial Cancer with iPSC Approaches 12.71
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 12.62
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 12.61
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 12.6
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 12.6
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 12.58
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 12.47
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 12.45
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 12.4
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 12.39
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 12.35
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 12.32
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 12.28
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 12.28
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 12.21
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 12.2
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 12.18
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 12.15
12.08
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 12.05
AUF-1 affected genes in human skin cells 12.04
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 12.02
IMP3 regulated gene expression in breast cancer cells 12.01
AMPK signaling for naïve pluripotency [Hs] 11.98
AMPK signaling for naïve pluripotency 11.98
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 11.93
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 11.9
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 11.9
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 11.89
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 11.85
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 11.83
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 11.81
ARID1A and ARID1B loss in HCT116 and TOV21G cells 11.79
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 11.77
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 11.75
ARS2 is a general suppressor of pervasive transcription [RNAseq] 11.69
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 11.64
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 11.54
11.5
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 11.45
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 11.45
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 11.43
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 11.43
In vivo genome editing restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers 11.32
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 11.31
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 11.28
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 11.2
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 11.19
The cohesin complex prevents Myc-induced replication stress 11.19
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 11.14
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 11.14
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 11.11
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 11.11
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 11.09
JunB control of keratinocyte-mediated inflammation [RNA-seq] 11.08
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 11.08
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 11.05
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 11.02
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 10.86
Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration 10.75
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 10.75
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 10.75
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 10.75
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 10.71
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 10.69
An integrative analysis of non-coding regulatory DNA variations associated with autism 10.65
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 10.57
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 10.56
CD73 knockdown effect in pancreatic cancer cell lines 10.48
Role of XRN2 ribonucleolytic activity in RNA metabolism 10.48
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 10.47
PTHrP overexpression in MCF7 cells 10.42
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 10.41
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 10.35
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 10.35
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 10.35
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 10.3
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 10.3
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 10.28
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 10.25
Functional role of CPPED1 in trophoblasts. 10.21
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 10.2
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 10.18
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 10.16
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 10.14
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 10.11
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 10.05
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 10.03
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 9.99
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 9.98
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 9.98
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 9.97
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 9.97
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 9.91
Functional astrocytes differentiated from hiPSCs 9.77
Reprogrammed myeloid cell transcriptomes in NSCLC 9.69
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 9.62
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 9.62
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 9.59
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 9.57
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor 9.56
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 9.44
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 9.3
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 9.3
High level DNA repair gene expression in human ES cells 9.26
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 9.23
RNA-seq of naive and primed ES cells 9.22
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 9.21
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 9.02
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 8.89
RNA-Seq in PWS iPSC-derived neurons 8.8
Next generation sequencing of small RNAs isolated from exosomes in human semen 8.68
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 8.49
RNA-seq analysis of the human fetal kidney. 8.33
Identification of differentially expressed genes between senescence and senescence bypass cells 8.24
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 8.2
Exogenous rescue of KLHL9 in SF210 cell line 8.17
The effect of insulin on mRNA transcription of human pluripotent stem cells 8.09
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 8.04
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 8.01
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 7.91
hESC neural differentiation 7.9
RNA-seq analysis of gene expression patterns during hESC neural differentiation 7.9
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 7.88
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 7.84
Gene expression profiling of human and murine in vitro muscle differentiation 7.81
Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord and chorionic plate under serum-free condition 7.64
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 7.58
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 7.57
nELAVL HITS-CLIP in Alzheimer's Disease patients 7.01
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 6.85
Effect of nuclear IL-33 on gene expression 6.73
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 6.7
An siRNA screen identifies CHD4 as a target for epigenetic therapy 6.59
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 6.52
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 6.4
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 6.38
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 6.36
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 6.03
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 5.98
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 5.9
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 5.9
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 5.87
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 5.8
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 5.74
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 5.64
HEK293 TFAM Knockout Expression Study 5.54
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 5.54
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 5.47
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 5.45
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 5.41
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 5.34
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 5.26
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 5.26
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 5.13
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 5.1
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 4.97
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 4.93
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 4.85
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 4.72
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 4.68
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 4.63
Activity-dependent transcriptional changes in human neurons 4.5
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 4.48
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 4.48
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 4.44
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 4.16
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 4.14
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 4.09
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 4.08
NKX2.2 4.08
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 4.08
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 4.02
FOXP2's impact on the primate transcriptome 3.99
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 3.94
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 3.66
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 3.65
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 3.59
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 3.45
Zika virus infection reprograms global transcription of host cells to allow sustained infection 3.22
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 3.21
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 3.12
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 3.12
Dissecting neural differentiation regulatory networks through epigenetic footprinting 3.1
Modeling Human Cancer-induced Cachexia (Human) 3.03
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 3.01
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 2.94
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 2.91
Metabolism as an early predictor of DPSCs aging 2.87
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 2.82
Age-Related Gene Expression Changes in Prostate Cancer Patients 2.53
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 2.53
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 2.47
High-resolution comparative analysis of great ape genomes 2.29
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 2.07
Gene expression regulated by CSA and CSB in neuroblastoma cell line 1.98
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 1.97
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 1.87
Genome-wide transcriptional response to random aneuploidy in human cells 1.82
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 1.61
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 1.6
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 1.4
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 1.25
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 1.22
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 1.22
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 1.2
Gene expression of collecting duct carcinoma of the kidney 1.16
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 1.14
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 0.98
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 0.96
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 0.96
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 0.94
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 0.91
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 0.91
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 0.87
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 0.87
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.86
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 0.82
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.8
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.7
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 0.63
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.58
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.56
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.56
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 0.48
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA 0.48
A549 cell transcriptome responses to infection with H7N9 influenza virus 0.46
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 0.43
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 0.43
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 0.36
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 0.32
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 0.26
Transcriptome-wide response to synthetic chromatin protein PcTF 0.14
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 0.12
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 0.12
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 0.12
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 0.07
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation